Eastside Clinical Research - CA Los Angeles, Los Angeles 90022

Eastside Clinical Research entered the industry of Clinics in 2008 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 6214930, which describes it as a Clinics. For further clarification, the SIC classifies this business under the code 8011 and described it as a Clinics. The business provides service to the B2C market.

To acquire more information, please contact Enrique Gonzales, Manager by calling (323) 261-4706 during business hours. You can also write to the business’ Single Location at 4755 East Cesar East Chavez Avenue # A, Los Angeles, California CA 90022. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Eastside Clinical Research
Representative: Enrique Gonzales, Manager
Place of Business: 4755 East Cesar East Chavez Avenue # A, Los Angeles, CA 90022
Contact Number: (323) 261-4706
Type of Service: Clinics
SIC Number: 8011
NAICS Number: 6214930
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2008
Income/Year: $1.000.000 to $2.499.999
Laborers: 1 to 4
Share This Company:

Eastside Clinical Research is a company operating from Los Angeles, California providing professional Clinics and relevant B2C variables. It was founded in 2008 and registered with the SIC code 8011 as Clinics, and with the NAICS code 6214930 as Clinics.

With a current employee count of 1 to 4, Eastside Clinical Research has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Enrique Gonzales, Manager at (323) 261-4706 for related queries, or to locate its Single Location using the coordinates 34.04064,-118.16299.

The Single Location can also be found at the street address 4755 East Cesar East Chavez Avenue # A in Los Angeles, California 90022 and can be engaged online through the company website at , the company Twitter , and Facebook page .